Physician profile
Peter Denberg
NPI 1699842245
$1,133.98
in general payments reported to CMS, 2019-2025
11 companies · $344 in 2025
The $344 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.41 · 2020: $79.45 · 2021: $87.78 · 2022: $62.11 · 2023: $262 · 2024: $225 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $351.66 | 2022-2025 | Cleviprex, Kengreal |
| Pacira Pharmaceuticals Incorporated | $303.00 | 2022-2025 | Exparel, Zilretta, Iovera |
| Merck Sharp & Dohme LLC | $195.69 | 2019-2025 | Bridion |
| Atricure, INC. | $58.97 | 2023 | |
| Edwards Lifesciences Corporation | $55.66 | 2020-2024 | |
| Mallinckrodt Enterprises LLC | $43.72 | 2019 | |
| Mallinckrodt Hospital Products INC. | $36.68 | 2020-2021 | |
| Fisher & Paykel Healthcare INC | $36.35 | 2023 | Fisher & Paykel Healthcare |
| Abbott Laboratories | $24.59 | 2023 | Xience Sierra |
| Masimo Corporation | $14.07 | 2021 | |
| Smith+Nephew, INC. | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Denberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.